Our achievements

Our mission is to discover and develop breakthrough cancer therapies to provide the best health outcomes for patients.

Our five core research programs are investigating and developing treatments for a broad spectrum of cancer types including breast, bowel, liver, lung, melanoma, gastrointestinal and brain cancer.



DSC01747 150813-jamesbraund-0123 180315 ONJCRI TT 0119

Our approach ensures the rapid translation of scientific discovery to breakthrough therapies.

Emerging discoveries from the laboratory are made available through trials for the benefit of cancer patients with Institute investigators overseeing 60-70 clinical trials any one time. Observations from the clinic are then investigated by our research team. We thereby create a continual cycle of learning and improvement between scientific research and care. 


We are committed to the continual discovery, development and trial of breakthrough therapies in the fight against cancer. The Hon. John Brumby, ONJCRI Chairman

Find out about our research programs

Learn more
Research test tubes

Research Studies

Across five core research programs, there are more than 140 research studies currently underway.



In 2017 our researchers published over 130 scientific papers.


Clinical Trials

Our researchers partner with clinicians and patients. In 2017 our Institute Investigators led 128 clinical trials.


School of Cancer Medicine

As the La Trobe University School of Cancer Medicine in 2017 we had 25 PhD and Honours students receiving world-class training in translational research.


Global Network

In 2017, we had 63 international researchers from 30 countries working to deliver high-impact translational research.


Clinician Scientists

In 2017, 13% of our staff were Clinician Scientists meaning they work in a clinical setting with patients while also conducting research within the Institute.